ReviewOncotarget2015

Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target.

Jianbiao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.